These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6436403)

  • 1. [Serovar and antibiotic-sensitivity of Serratia marcescens isolated from urinary tract infections].
    Okuda T; Hirosawa Y; Enda N; Zenyoji H
    Kansenshogaku Zasshi; 1984 Jun; 58(6):483-90. PubMed ID: 6436403
    [No Abstract]   [Full Text] [Related]  

  • 2. Serratia marcescens: biochemical, serological, and epidemiological characteristics and antibiotic susceptibility of strains isolated at Boston City Hospital.
    Wilfert JN; Barrett FF; Ewing WH; Finland M; Kass EH
    Appl Microbiol; 1970 Feb; 19(2):345-52. PubMed ID: 4314379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Utility of serotyping in the study of Serratia marcescens infections in Strasbourg Hospitals (author's transl)].
    Minck R; Le Minor S; Pigache F; Dammron A; Reeb E; Kohen M; Le Faou A
    Pathol Biol (Paris); 1980 Oct; 28(8):501-7. PubMed ID: 7001322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Urinary tract infections due to Serratia marcescens. I. Antimicrobial susceptibility patterns of clinical isolates of Serratia marcescens (author's transl)].
    Igari J; Kosakai N
    Jpn J Antibiot; 1977 Oct; 30(10):840-6. PubMed ID: 338940
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical studies on urinary tract infections caused by Serratia marcescens. I. Clinical and bacteriological studies on urinary tract infections caused by Serratia marcescens].
    Sakai S; Kumamoto Y
    Nihon Hinyokika Gakkai Zasshi; 1983 Apr; 74(4):467-84. PubMed ID: 6353020
    [No Abstract]   [Full Text] [Related]  

  • 6. Serratia marcescens infections.
    Acar JF
    Infect Control; 1986 May; 7(5):273-8. PubMed ID: 3519496
    [No Abstract]   [Full Text] [Related]  

  • 7. Endemic Serratia marcescens in the Veterans Administration Hospital in Pittsburgh, Pa., 1971--1976.
    Brown A; Davis L; Yee RB; Postic B
    Health Lab Sci; 1978 Jul; 15(3):159-67. PubMed ID: 359506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial susceptibility of Serratia marcescens isolated from clinical materials.
    Igari J; Oguri T; Kosakai N
    Jpn J Antibiot; 1984 Sep; 37(9):1625-30. PubMed ID: 6392599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study on serotyping, phage typing and drug resistance of Serratia marcescens isolated from clinical specimens (author's transl)].
    Morishita H
    Nihon Hinyokika Gakkai Zasshi; 1980 Nov; 71(11):1313-27. PubMed ID: 7007698
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical aspects of urinary tract infection by Serratia marcescens].
    Miyakita H; Kawashima T; Kinoshita H; Kawamura N
    Hinyokika Kiyo; 1984 Feb; 30(2):153-8. PubMed ID: 6377857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serratia marcescens as an opportunistic human pathogen].
    Yokota M; Okazawa A; Tanaka T
    Nihon Saikingaku Zasshi; 2001; 56(3):527-35. PubMed ID: 11577410
    [No Abstract]   [Full Text] [Related]  

  • 12. [Statistical observation of urinary tract infections by Serratia marcescens].
    Kamiryo Y; Sakatoku J
    Hinyokika Kiyo; 1983 Apr; 29(4):401-10. PubMed ID: 6203384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical studies on urinary tract infections caused by Serratia marcescens. II. Epidemiological studies on onset of Serratia marcescens urinary tract infections in the urological ward].
    Sakai S; Nishio A; Kumamoto Y
    Nihon Hinyokika Gakkai Zasshi; 1983 Apr; 74(4):485-502. PubMed ID: 6353021
    [No Abstract]   [Full Text] [Related]  

  • 14. [Uropathogenic Serratia marcescens of hospital origin: analysis of the adhesion mechanism of 2 strains].
    Padilla C; Brevis P; Padilla R
    Rev Med Chil; 1989 Jun; 117(6):629-35. PubMed ID: 2519411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bactericidal activity of the complement and its synergistic effects with cephem antibiotics against Serratia marcescens].
    Kiyota H; Onodera S; Kishimoto K; Goto H; Machida T; Yokota T
    Nihon Hinyokika Gakkai Zasshi; 1988 May; 79(5):910-7. PubMed ID: 3070107
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibiotic-resistant Serratia marcescens infection in a hospital.
    Ambrosio RE; Van Wyk AJ; De Klerk HC
    S Afr Med J; 1979 Apr; 55(15):584-7. PubMed ID: 380020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amikacin therapy of patients with multiply antibiotic-resistant Serratia marcescens infections: development of increasing resistance during therapy.
    Craven PC; Jorgensen JH; Kaspar RL; Drutz DJ
    Am J Med; 1977 Jun; 62(6):902-10. PubMed ID: 326046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacteriocin typing of Serratia marcescens. A simplified system.
    Sproat D; Brown A
    Am J Clin Pathol; 1979 Feb; 71(2):172-6. PubMed ID: 371382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nosocomial epidemic of antibiotic-resistant Serratia marcescens urinary tract infections.
    Krieger JN; Levy-Zombek E; Scheidt A; Drusin LM
    J Urol; 1980 Oct; 124(4):498-502. PubMed ID: 6999177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sero-types and drug sensitivity of Serratia marcescens isolated from pathological specimens, with special reference to hospital infections. II. (author's transl)].
    Yama H; Yamada K; Tsujimoto T
    Jpn J Antibiot; 1979 Jun; 32(6):661-7. PubMed ID: 381707
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.